NPSP

{"sector":"Healthcare","industry":"Drugs","symbol":"NPSP","company_name":"NPS Pharmaceuticals, Inc.","exchange":"NASDAQ"}

NPSP Articles

Tuesday's top analyst upgrades, downgrades and initiations seen from Wall Street research calls include GE, Gilead Sciences, Oracle, Under Armour and El Pollo Loco.
A new report from Merrill Lynch highlights five biotechs that have been absolutely crushed but have outstanding potential and catalysts that can drive them much higher.
NPS Pharmaceuticals traded lower on what sounded like good news. The problem is that headlines often do not reveal the true underlying story.
Source: ThinkstockNPS Pharmaceuticals, Inc. (NASDAQ: NPSP) is up huge in regular trading on Wednesday, due to positive preliminary results of a clinical trial. The FDA has posted the briefing...
In a new research report, the J.P. Morgan health care team highlights their top names to buy after the sell-off that may provide investors some incredible outsized gains over the rest of the year.
These are the top analyst upgrades, downgrades and initiations from Wall Street on Wednesday, April 16, 2014. They include Control4, Cree, NetApp, Twitter, Yahoo! and Yelp.
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Tuesday, March 25, 2014. They include Arch Coal, BlackBerry, Himax Technologies, Palo Alto...
In a new research report, the boutique firm Leerink highlights 10 top biotech names that are strong candidates for a partnership or acquisition. Any of these picks may be a great addition for...
Source: ThinkstockMost of the major mega cap biotechnology companies have reported earnings and the results almost across the board have been very good. The problem for many investors is many of the...
As the stock market is challenging all-time highs around a holiday week, investors have to be considering how to position their portfolios and assets for 2014 and beyond. 24/7 Wall St. has been...
Source: ThinkstockAny time investors look for companies growing sales the most, one area that almost always stands out is the up and coming biotech stocks. After all, sales can grow from close to...
NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) may not yet have formal approval for its short bowel syndrome drug called Gattex, but it has at least received a panel back at the Food & Drug...
How many big movers can you see in one day in the biotech sector?  This is what investors should be asking.  If you didn’t know better you might think there was a collusion in the biotech space...
For today’s winners and losers, two of the four companies on the lists today are pharmaceutical companies, moving on action from drug regulators. One of them, Arena Pharmaceuticals, has seen its...
Markets opened lower this morning, and continued to fall before holding at around -150 points for most of the day on the DJIA. Japan’s yen sale pushed the dollar sharply higher and pushed down...